Michael Coleman, PhD

Mike completed his PhD in Biochemistry and Cell Biology at the University College Cork in Ireland, where his work examined the role of growth factor signaling in mitochondrial homeostasis. He joined the Hursting lab for postdoctoral training in 2017 to explore systemic and cellular metabolic determinants of cancer therapy outcomes. He is now based in Chapel Hill, but fondly remembers the first half of his postdoctoral training at the NRI.